; and (E) other areas determined appropriate by the Secretary. (3) Evaluation and report (A) Evaluation The Secretary shall, at least every 2 years, evaluate the implementation of the Action Plan under this section to provide any updates or modifications to such plan. (B) Report Not later than 18 months after the date on which the Action Plan developed under paragraph (1) is released, the Secretary shall submit to Congress a report that discusses any updated recommendations for updates or modifications considering initial progress made in advancing the action plan's goals or barriers to attaining such goals. (f) Report regarding liver cancer Not later than 1 year after the date on which the first meeting of the working group is held, the working group shall transmit to the Director of the NIH a report providing recommendations with respect to preventive and diagnostic measures that could, in consideration of the relationship between the prevalence of liver cancer and the prevalence of certain liver diseases, help reduce liver cancer rates and make liver cancer more treatable when detected. 7. Renaming of NIH institute to reflect liver diseases and creation of division of liver diseases (a) Institute renamed Effective on January 1, 2021, title IV of the Public Health Service Act is amended by striking National Institute for Diabetes and Digestive and Kidney Diseases each place it appears in section 401(b) ( 42 U.S.C. 281(b) ), in section 409A(a) ( 42 U.S.C. 284a(a) ), in the heading of subpart 3 of part C, in section 426 ( 42 U.S.C. 285c ), and section 430 ( 42 U.S.C. 285c–4 ) and inserting The National Institute of Diabetes and Digestive, Kidney, and Liver Diseases . (b) Conforming changes Effective on January 1, 2021, any reference to the National Institute for Diabetes and Digestive and Kidney Diseases in any law, regulation, document, record, or other paper of the United States shall be deemed to be a reference to the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases. (c) Establishment